Abstract
Market Highlights:
Valued at over $1 billion in 2004,the US matket for orthopedic biomaterials
was comprised of the following segments:
- Bone graft substitutes(BGS)
- Spinal machined bone
- Osteoarticular allografts
- Hyaluronic acid injections
- Emerging growth factor technologies
- Platelet concentration systems
- Autologous chondrocyte implantation
The market for orthopedic biomaterinls is driven by the need for better
solutions to aiments and dlseases, such as dagenerative disc disease and
osteaarthritis,resulting from an ever increasingly active and aging population.
Better understand the US Orthopedic Biomaterials Market. Receive the most
up-to-date data available on procedure volumes and unit sales, market value,
and market shares, Contrast effective strategies employed by industry leaders
to create and sustain market share.
View Cart
